The promoter of the human adenovirus type 2 IVa 2 gene, which becomes active only during the late phase of infection, is built largely from sequences spanning, and downstream of, the sites of initiation of transcription. These sequences comprise an initiator, an intragenic sequence necessary for efficient transcription from the promoter by RNA polymerase II, and an intragenic binding site for a cellular repressor of IVa 2 transcription. The properties of the latter protein, which is termed IVa 2 -RF, suggested that it might account for the viral DNA synthesis-dependent activation of IVa 2 transcription during the adenoviral productive cycle. Here we report the results of experiments to assess the contributions of DNA template concentration and IVa 2 -RF binding to the activity of the IVa 2 promoter using a transient expression system. When a IVa 2 -EGFP reporter gene was introduced into HeLa cells, in which IVa 2 -RF was identified, no EFGP synthesis could be detected. In contrast, in IVa 2 -RF-containing cells in which the plasmid carrying the chimeric gene replicated, synthesis of both the EGFP protein and the IVa 2 -EGFP mRNA was readily detected. A vector mutation that blocked plasmid replication reduced IVa 2 promoter activity to undetectable levels. In contrast, a IVa 2 promoter substitution that impaired binding of IVa 2 -RF increased IVa 2 promoter activity under all conditions examined. Furthermore, introduction of DNA containing the IV-RF binding site with the chimeric reporter genes resulted in increased transcription from the IVa 2 promoter in the absence of plasmid replication. These properties are consistent with the hypothesis that the relative concentration of the IVa 2 promoter and of the cellular repressor that binds to it governs transcription from this adenoviral promoter.
Introduction
The productive cycle of human subgroup C adenoviruses such as adenovirus type 2 (Ad2) is characterized by strict, sequential expression of viral genes (see Shenk, 2001 ). This program is established primarily by mechanisms that regulate transcription by RNA polymerase II. The E1A transcription unit includes an enhancer that is recognized by cellular proteins alone Shenk, 1983, 1986 ). This gene is therefore transcribed efficiently as soon as the viral genome enters the nucleus at the beginning of the infectious cycle. During the early phase of infection, alternative splicing of E1A pre-mRNA produces two predominant mRNAs, which encode 243 and 289 amino acid proteins that differ only in the presence of a unique, internal sequence in the latter (see Shenk, 2001; Shenk and Flint, 1991) . The larger E1A protein activates transcription from all viral early genes via a variety of cellular transcriptional regulators (see Flint and Shenk, 1997) . It is therefore necessary for successful progression beyond the immediateearly phase of infection under typical conditions of infection (Berk et al., 1979; Jones and Shenk, 1979; Nevins, 1981) . Both the 243R and the 289R E1A proteins can also stimulate transcription from the viral early E2 promoter (E2E) as a result of their ability to release cellular, sequence-specific activators of the E2F family from association with hypophosphorylated Rb, a transcriptional repressor (see Nevins, 1992; Shenk and Flint, 1991) . Efficient transcription from the E2E promoter sets the stage for the transition into the late phase of infection, for the E2 transcription unit encodes the viral replication proteins (see Flint, 1986; Shenk, 2001) .
Early studies established that synthesis of viral late mRNAs and proteins requires viral DNA synthesis in in-fected cells (see Flint, 1986; Shenk, 2001) . In fact, initiation of viral genome replication once E2 proteins have attained an appropriate intranuclear concentration leads to three distinct types of transcriptional alteration. In the first place, three viral promoters (pIX, IVa 2 , and E2 late) that are silent during the early phase of infection become active (see Flint, 1986; Shenk, 2001 ). In addition, transcription of the major late (ML) transcription unit terminates close to the right end of the genome (Fraser et al., 1979) , rather than at many sites within a large sequence near the middle of the transcription unit, the pattern observed prior to viral DNA synthesis (Akusjärvi and Persson, 1981; Iwamoto et al., 1986; Shaw and Ziff, 1980) . The mechanism by which termination of ML transcription is regulated is not known, but the switch in termination might be governed by differences in the association with proteins of entering viral DNA molecules and those produced within the infected cell. Finally, the efficiency of ML transcription increases some 20-to 30-fold with the transition into the late phase of infection (Shaw and Ziff, 1980) . Such late phase-specific stimulation of ML transcription requires promoter sequences located at positions ϩ86 to ϩ96 (DEF1) and positions ϩ113 to ϩ124 (DEF2) of the ML transcription unit in both in vitro transcription systems and infected cells (Jansen-Durr et al., 1988; Leong et al., 1990; Mansour et al., 1986; Mason et al., 1990) . These sequences are recognized by proteins present only in infected cells (Jansen-Durr et al., 1988 , 1989 Leong et al., 1990; Mondesert et al., 1992) . The protein termed DefB, which binds to DEF2, is a dimer of the viral late IVa 2 protein (IVa 2 p), whereas DefA, which binds specifically to DEF1, contains IVa 2 p and one or more additional, infected cell-specific proteins that have not yet been identified (Lutz and Kedinger, 1996; Tribouley et al., 1994) . The IVa 2 protein is the only sequence-specific transcriptional activator encoded within the adenoviral genome, although its sequences required for DNA binding do not conform to those of any well-characterized DNA-binding motif (Lutz and Kedinger, 1996) . Stimulation of ML transcription by the IVa 2 protein in infected cells remains to be demonstrated directly, in part because IVa 2 p also is responsible for recognition of the viral DNA packaging signal and therefore essential for assembly of virus particles Imperiale, 2000, 2003) . However the observation that the IVa 2 protein stimulates ML transcription in a transient expression assay via the internal promoter sequences listed above (Tribouley et al., 1994) is consistent with such a role. Such dependence of efficient ML transcription on synthesis of the IVa 2 protein would imply that the crucial step in establishing the late-phase transcriptional program in adenovirusinfected cells is DNA synthesis-dependent activation of transcription from the IVa 2 promoter.
In previous studies, we identified a cellular protein that represses IVa 2 transcription by binding to an internal sequence of the viral promoter (Chen et al., 1994; Lin and Flint, 2000) . The promoter sequence contacted by this repressor, which is currently termed IVa 2 -RF, lies between, and is partially superimposed on, both the initiator element and an internal sequence essential for efficient initiation of IVa 2 transcription (Chen et al., 1994; Lin and Flint, 2000) . Adenovirus infection does not result in reduced activity of IVa 2 -RF (Lin and Flint, 2000) . We therefore proposed that the IVa 2 promoter becomes active in infected cells only when viral DNA synthesis increases its concentration above that at which all copies can be bound by the repressor. Here we report the results of experiments demonstrating DNA synthesis-dependent titration of the repressor of IVa 2 transcription in a simplified experimental system.
Results and discussion

Replication-competent plasmids containing IVa 2 -EGFP reporter genes
To test the hypothesis that the activity of the Ad2 IVa 2 promoter is controlled by the relative concentrations of the cellular repressor of its transcription, IVa 2 -RF, and the binding sites for this protein in the IVa 2 promoter, the latter promoter was introduced into a plasmid vector that can replicate in mammalian cells under appropriate conditions. This vector contains the SV40 origin of replication, which is recognized by SV40 large T antigen (LT), the only viral protein required for replication from this origin (Diffley, 1992; Fanning, 1994) . The Ad2 IVa 2 promoter, or a mutant derivative (Rep6) containing a substitution that decreases the affinity of IVa 2 -RF for its binding site some five-fold (Lin and Flint, 2000) , was introduced upstream of an EGFP reporter gene in the SV40-origin containing vector (Fig. 1) , as described under Materials and methods. Sibling vectors that cannot replicate even in the presence of LT were constructed by mutation of the SV40 origin binding for LT, which is essential for replication from this origin (see DePamphilis, 1993; Fanning, 1994) . This mutation inhibited synthesis of vector DNAs in LT-producing cells as expected (see Fig. 5B ). These origin-lacking vectors also provided controls for any effects of SV40 LT on the activity of the adenoviral IVa 2 promoters: LT is not only the origin recognition protein of SV40, but also activates viral late transcription (Brady et al., 1984; Keller and Alwine, 1984) and can stimulate transcription from many promoters in transient expression assays (Damania and Alwine, 1996) .
The Ad2 IVa 2 promoter is inactive in uninfected HeLa cells
The activity of the IVa 2 promoter was first examined in Hela cells, in which IVa 2 -RF was identified (Chen et al., 1994) . These cells do not contain coding sequences for SV40 LT and therefore cannot support replication of the vectors described in the previous section. The SV40 origincontaining plasmids were introduced into HeLa cells by the calcium phosphate coprecipitation method and EGFP autofluorescence was examined 24 to 72 h later, as described under Materials and methods. The strong, constitutive, human cytomegalovirus immediate-early promoter in the same vector was introduced into parallel cultures as a positive control. A significant fraction of the cells that received the latter plasmid exhibited a strong EGFP signal (Fig. 2) . In contrast, no cells into which the wild-type (wt) IVa 2 -EGFP reporter gene was introduced synthesized such high concentrations of the protein, and only a small number exhibited much weaker EGFP autofluorescence at any time examined (Fig. 2) . Furthermore, the Rep6 promoter mutation did not increase the number of cells synthesizing EGFP (data not shown).
Our in vitro analyses of the organization of the IVa 2 promoter employed HeLa cell extracts competent for transcription by RNA polymerase II (Kasai et al., 1992; Chen and Flint, 1992; Chen et al., 1994) . Such systems support quite efficient IVa 2 transcription, but only at specific ratios of extract proteins to template DNA concentrations: as the concentration of HeLa cell proteins was increased above an optimal value, the efficiency of IVa 2 transcription was observed to decrease sharply (Leong and Flint, 1984) , a property subsequently attributed to inhibition by IVa 2 -RF (Chen et al., 1994) . The results described here indicate that the HeLa cells contain a sufficient concentration of IVa 2 -RF to block transcription from even the relatively large number of IVa 2 promoters that is likely to be introduced into individual cells by DNA-mediated transformation. They are therefore consistent with one crucial tenet of the repressor titration hypothesis described in the introduction.
COS-1 cells contain IVa 2 -RF
Cells of the COS-1 line, which was derived from African monkey kidney CV1 cells, synthesize large quantities of SV40 LT constitutively and support DNA synthesis from the SV40 origin of replication (Gluzman, 1981) . To determine whether these cells were suitable for analysis of the effects on DNA replication on the activity of the Ad2 IVa 2 promoter, we assayed whole-cell extracts prepared from them for IVa 2 -RF activity, using the electrophoretic mobility shift method described under Materials and methods. When COS-1 cell proteins were incubated with a synthetic, 32 P-labeled DNA fragment containing the IVa 2 -RF binding site of the IVa 2 promoter, a complex of low mobility that comigrated with a complex formed by HeLa cell proteins was observed (Fig. 3 , lanes 2 and 8). The unlabeled IVa 2 DNA sequence effectively blocked formation of both the HeLa and the COS-1 protein-DNA complexes, but a DNA fragment containing the Rep6 mutation, which impairs binding of human IVa 2 -RF (Lin and Flint, 2000) , was a much less effective competitor (Fig. 3 , compare lanes 3-6 to lane 2 and lanes 9 -12 to lane 8). These data establish that As shown, the IVa 2 promoter directs expression of the EGFP reporter gene (gray) in the plasmids used in these experiments. The sequences required for transcription from this promoter extend from positions Ϫ5 to ϩ31 Chen et al., 1994) . Sequences contacted by IVa 2 -RF are indicated by the shaded oval. The IVa 2 promoter sequence contacted by IVa 2 -RF (Chen et al., 1994) is listed above, and the substitutions present in the Rep6 promoter are indicated in bold, oblique face. These substitutions alter the central segment of the IVa 2 -RF binding site that is not also part of the initiator or essential, intragenic stimulatory elements (Lin and Flint, 2000) . As indicated, this segment of viral DNA was introduced into the multiple cloning site of pEGFP-1 (Clontech) to construct chimeric IVa 2 -EGFP reporter genes. The position of the SV40 origin is indicated.
simian COS-1 cells contain IVa 2 -RF activity. Moreover, the results of experiments in which the formation of the IVa 2 -RF complex was examined as a function of extract protein concentration (data not shown) indicated that the concentrations of the repressor in HeLa and COS-1 cell extracts were similar.
Replication-dependent activity of the IVa 2 promoter in COS-1 cells
To investigate the effects of increased intracellular DNA concentration on control of IVa 2 promoter activity by IVa 2 -RF, the SV40 origin-containing and -lacking plasmids carrying chimeric IVa 2 -EGFP genes were introduced into COS-1 cells, and reporter gene expression was examined initially using EGFP autofluorescence. In contrast to the results obtained with HeLa cells, a substantial fraction of COS-1 cells receiving wt IVa 2 -EGFP in the origin-containing vector exhibited moderate-to-strong fluorescence (Fig.  4) . The exact proportion of such EGFP-synthesizing cells varied from experiment to experiment (Table 1) . Nevertheless, efficient synthesis of EGFP required the presence of a functional origin of replication in the vector: the mutation that eliminated the origin both substantially reduced the number of cells in which EGFP could be detected (Table 1) and the strength of the fluorescent signal in those cells synthesizing EGFP (Fig. 4) . We can therefore conclude that expression of the chimeric IVa 2 -EGFP gene in COS-1 cells is not the result of stimulation of transcription from the adenoviral promoter by SV40 LT, but rather correlated with the ability of the vector DNA to replicate.
The activity of the IVa 2 promoter carrying the Rep6 substitution was also compared to that of the wild-type. This mutation reproducibly resulted in synthesis of EGFP in a slightly higher fraction of cells, but this increase was too small to be considered significant (Table 1) . Because the Rep6 mutation decreases the affinity with which IVa 2 -RF binds to the IVa 2 promoter by some five-fold, and increases the efficiency of IVa 2 transcription in vitro, this minimal effect of the Rep mutation was somewhat unexpected. However, it seemed possible that the reporter genes reached sufficiently high concentrations in the period before EGFP autofluorescence was examined to obscure any difference in the initial rates of transcription from the wild-type and mutant promoters. Furthermore, although convenient and rapid, examination of EGFP autofluorescence does not provide a quantitative measure of reporter gene expression and hence promoter activity. For example, the quantities of EGFP produced in individual cells varied considerably (e.g., Fig. 4) , a parameter that is difficult to quantify, and ignored in a simple count of cells positive above a particular (subjective) threshold. Such considerations prompted direct examination of the synthesis of chimeric IVa 2 -EGFP mRNAs in cells containing the wild-type and Rep6 reporter genes.
Cytoplasmic and nuclear fractions were prepared from COS-1 cells into which the various vectors had been introduced and RNA was purified from the former fraction as described under Materials and methods. Chimeric IVa 2 -EGFP mRNA was assayed using primer extension from a primer complementary to a 25-nucleotide sequence within the EGFP coding sequence. Low-molecular-mass DNA was isolated from the nuclear fraction of each sample, and the vector DNA was examined by hybridization to an internal fragment of the EGFP gene following transfer of the DNA to nylon membranes, as described under Materials and methods. The results of one such experiment are shown in Table 2 .
The 89-nucleotide-long cDNA product predicted for primer extension of the chimeric mRNA was detected in RNA preparations made from COS-I cells into which the SV40 origin-containing vectors were introduced (Fig. 5A , lanes 3, 4, 7, and 8). However, no chimeric mRNA was evident in the corresponding RNA preparations from cells that had received the origin-lacking plasmids (Fig. 5A , lanes 5, 6, 9, and 10). As illustrated in Fig. 5B , the vector DNAs were nevertheless present in the nuclei of such cells, although, as expected, at substantially lower concentrations than those attained by the origin-containing DNAs. These results therefore confirmed that the activity of the IVa 2 promoter is governed by promoter concentration. Furthermore, the results obtained when the activity of the Rep6 mutant promoter was compared to that of the wild-type established that this property is not merely a result of the greater ability of the viral promoter to compete for components of the cellular transcriptional machinery when its concentration is increased by plasmid replication. The Rep6 mutation resulted in a significant increase in chimeric mRNA concentration compared to that observed in cells containing the wild-type IVa 2 -EGFP reporter gene ( Fig. 5A ; compare lanes 3 and 7 and lanes 4 and 8). In this experiment, the vector containing the mutant promoter accumulated to a slightly higher concentration than its sibling carrying the wild-type (Fig. 5B) . However, this difference was far too small to account for the ϳ10-fold difference in the corresponding chimeric mRNA concentrations determined by PhosphorImager analysis ( Fig. 5A ; Table 2 ).
An internal control plasmid was introduced into COS-1 cells with the IVa 2 -EGFP-containing vectors in experiments similar to that shown in Fig. 5 . However, we invariably observed synthesis of concentrations of control mRNAs too low for reliable quantification, regardless of whether an RSV-neomycin or an HCMV-luciferase reporter gene was used. Such poor expression of widely used reporter genes was presumably a result of the low concentrations of their promoters, which were introduced into COS-1 cells in nonreplicating plasmids, in the cells that also contained high concentrations of the IVa 2 -EGFP reporter genes. To obtain a quantitative measure of the effects of the Rep6 mutation, we therefore determined the concentrations of both the chimeric IVa 2 -EGFP mRNA and the vector DNA using the methods described above. In these experiments, only the SV40 origin containing vectors were employed, and such parameters as quantities of DNA were introduced and time of incubation following DNA introduction were varied. The data collected in such experiments, one of which is shown in Fig. 6 , were used to calculate ratios of reporter mRNA concentrations to those of the DNA template. Under all conditions tested, IVa 2 -EGFP mRNA synthesis normalized in this way to template concentration was more efficient from the Rep6 than from the wild-type IVa 2 promoter (Table 3). The mutation increased the activity of the IVa 2 promoter from three-to nine-fold under the various experimental conditions (Table 3) . As the magnitude of this difference could not be clearly correlated with any particular experimental parameter, the variability observed is likely to be due to differences in the efficiencies with which cells took up DNA and in the rates of plasmid replication in different experiments. Regardless, the greater efficiency of reporter gene expression from the Rep6 promoter observed in every experiment establishes that IVa 2 -RF represses IVa 2 transcription in vivo.
The methods employed in these studies assess the total concentrations of mRNA or DNA accumulated during the period in which cells containing the vector DNAs were incubated. Nevertheless, the patterns of IVa 2 -EGFP mRNA concentration per unit of DNA as a function of time are consistent with the view that the IVa 2 promoter becomes active only above a certain threshold concentration. This parameter increased more or less continuously when expression of the EGFP gene was controlled by the Rep6 promoter (Fig. 6) , suggesting that the promoter concentration attained by the time the analysis began was sufficient to support the maximal rate of transcription. In contrast, the chimeric mRNA accumulation as a function of concentration of the wild-type IVa 2 -EGFP DNA template increased substantially only during the latest period examined (Fig. 6 ). This property indicates that some threshold concentration of the IVa 2 promoter, at which all copies cannot be bound by IVa 2 -RF, must be attained to permit transcription from it. As a further test of the conclusion that the relative concentrations of IVa 2 -RF and the promoter govern IVa 2 transcription, we sought to decrease the effective concentration of the repressor by introduction of its DNA-binding site. Increasing quantities of the synthetic DNA containing the IVa 2 -RF binding site described previously were therefore introduced into COS-1 cells with a fixed concentration of the origin-lacking plasmid containing the wild-type IVa 2 -EGFP reporter gene. As this plasmid cannot replicate, the IVa 2 promoter was maintained at a fixed concentration as the concentration of exogenously added IVa 2 -RF DNA was increased. Promoter activity was then assessed by examination of EGFP autofluorescence. As shown in Fig. 7 , the activity of the IVa 2 promoter increased, up to 8.5-fold, as a function of the quantity of IVa 2 -RF DNA was also introduced. Furthermore, the Rep6 mutation increased promoter activity in the presence, but not in the absence, of the competitor DNA.
The properties of IVa 2 transcription in the transient expression system employed in these experiments are fully consistent with the hypothesis that transcription from this adenoviral promoter is governed by the relative concentrations of the promoter and of the cellular repressor that binds to it. The IVa 2 promoter was inactive whenever its intracellular concentrations were limited to those introduced by DNA-mediated transformation ( Figs. 2 and 5 ; Table 2 ).
Increased promoter concentration as a result of vector replication from the SV40 origin (Fig. 5B ) increased transcription from the wild-type IVa 2 promoter (Figs. 4 and 5A ; Tables 1 and 2) , as did introduction of competitor DNA containing the IVa 2 -RF binding site of the viral promoter (Fig. 7) . A mutant IVa 2 promoter containing the Rep6 substitution, which decreases the affinity with which IVa 2 -RF binds to DNA (Lin and Flint, 2000) , was invariably more active than the wild-type ( Fig. 6; Table 3 ). It is also clear that HeLa cells contain sufficient IVa 2 -RF to block transcription from even the relatively large number of IVa 2 promoter-containing DNA molecules introduced per cell by DNA-mediated transformation (Fig. 2) . This property suggests that the absence of IVa 2 transcription during the early phase of the infectious cycle is the result of binding of IVa 2 -RF to the IVa 2 promoters of all infecting genomes. On the other hand, the results described here cannot establish whether increased IVa 2 promoter concentration following viral DNA synthesis is sufficient to overcome IVa 2 -RF-mediated repression in infected cells, as in this simplified experimental system, or whether additional, infected cell-specific parameters are also important. The Rep6 mutation, and others that reduce the affinity which IVa 2 -RF binds to the IVa 2 promoter (Lin and Flint, 2000) , have therefore been introduced into the endogenous Ad5 IVa 2 promoter, so that this issue can be addressed.
Materials and methods
Cells, plasmids, and DNA-mediated transformation
HeLa and COS-1 cells were maintained in monolayer cultures in Dulbecco's modified Eagle's medium (Gibco-BRL) supplemented with 10% calf serum and 10% fetal calf serum (Gemini), respectively.
A SacII Ad2 DNA fragment extending from positions ϩ32 of the IVa 2 to position ϩ131 of the ML transcription units (Fig. 1) was ligated into the multiple cloning site of SV40 origin-containing plasmid pEGFP-1 (Clontech). Products with the IVa 2 promoter upstream of the EGFP coding sequence were identified by restriction endonuclease digestion. A plasmid containing the Rep6 mutant IVa 2 promoter ( Fig. 1) was constructed in the same manner. Derivatives of these plasmids, which are designated pWTIVa 2 EGFP-Oriϩ and pRep6IVa 2 EGFP-Oriϩ, respectively, with nonfunctional origins of replication were then isolated: the essential origin binding site for SV40 large T-antigen was replaced by an unrelated sequence by the unique site elimination method (Deng and Nicholson, 1992) , and the recovery of the mutation was confirmed by sequencing. Plasmid DNAs were purified from Escherichia coli by the Qiagen maxiprep protocol and their quality was checked by electrophoresis in 1% agarose gels cast and run in TAE.
The vector DNAs were introduced into HeLa or COS-1 cells at ϳ70% confluence by the calcium phosphate coprecipitation method (Graham and van der Eb, 1973) . Various concentrations of vector DNAs, 2.5 g internal control DNAs and 25 g salmon sperm DNA, were mixed prior to precipitation. Cells were incubated with the precipitates for 10 min at room temperature, and fresh medium was then added. Following incubation at 37°C, the medium and precipitate were removed and the cells were washed twice with phosphate-buffered saline (Gibco-BRL) prewarmed to 37°C, prior to addition of fresh medium. In most experiments, this step was performed 18 h after addition of the DNA-containing precipitates and was defined as time zero. Incubation at 37°C was continued for the periods indicated in the figure legends and tables.
Electrophoretic mobility shift assay for IVa 2 -RF
Whole-cell extracts were prepared in parallel from actively growing HeLa and COS-1 cells as described previously Leong and Flint, 1984) . Protein concentrations were determined by the method of Bradford (Bradford, 1976) . A synthetic, double-stranded DNA fragment containing the sequence of the IVa 2 -RF binding site of the IVa 2 promoter (positions ϩ2 to ϩ35) was 32 P-labeled using [␥-32 P]ATP (3000 Ci/mmol, NEN) and polynucleotide kinase. Binding of IVa 2 -RF to this DNA was examined under the conditions described previously (Chen et al., 1994) . Some binding reactions contained varying concentrations of unlabeled competitor DNAs with the wild-type sequence or carrying the Rep6 substitution (Lin and Flint, 2000) . Electrophoresis and autoradiography were as described (Chen et al., 1994) .
Analysis of mRNA
COS-1 cells into which vectors carrying chimeric IVa 2 -EGFP genes had been introduced were harvested after various periods of incubation up to 72 h, where time zero was defined as described in a previous section. Cells were washed with ice-cold phosphate-buffered saline (Gibco-BRL) and cytoplasmic and nuclear fractions were separated by extraction with NP-40 as described (Kasai et al., 1992) . Total RNA was purified from the cytoplasmic fraction by digestion with proteinase K and phenol:chloroform extraction. The IVa 2 -EGFP mRNA was assayed by extension from a primer complementary to positions ϩ64 to ϩ89 of the coding strand of the chimeric transcription unit, as described previously (Kasai et al., 1992) . The specific primer extension products were quantified using a Molecular Dynamics PhosphorImager.
Analysis of plasmid DNA concentrations
Low-molecular-mass DNA was purified from the nuclear fractions described in the previous section by the Hirt procedure (Finnen et al., 2001; Hirt, 1967) . The DNA samples were linearized by digestion with HindIII, denatured, and loaded onto nylon membranes as described previously (Finnen et al., 2001; Hirt, 1967) . Membranes were then hybridized to an internal fragment of the EGFP coding sequence labeled by the random priming method (Feinberg and Vogelstein, 1983) . Signals were detected by autoradiography and quantified using a Molecular Dynamics PhosphorImager.
